Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07650032 · ClinicalTrials.gov registry record · NA
Cryoablation for Monomorphic Ventricular Tachycardia (VTS)
A NA study, sponsored by Adagio Medical.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07650032 is a NA study that has not yet begun recruiting, run by Adagio Medical. The registered enrollment target is 100 participants.
The verdict
NCT07650032, a NA study, has not yet begun recruiting, sponsored by Adagio Medical.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The objective of this clinical study is to evaluate the safety and effectiveness of the Adagio Medical vCLAS Ventricular Ablation System (including VTS Catheter and Console) in the ablation treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)
Interventions
- DEVICE Ultra Low Temperature Ablation (ULTA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07650032
The ClinicalTrials.gov registry entry for NCT07650032 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Adagio Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ultra Low Temperature Ablation (ULTA) is the first listed.
NCT07650032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07650032 about?
NCT07650032 is a clinical study titled "Cryoablation for Monomorphic Ventricular Tachycardia (VTS)". The objective of this clinical study is to evaluate the safety and effectiveness of the Adagio Medical vCLAS Ventricular Ablation System (including VTS Catheter and Console) in the ablation treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)
What is the current status of trial NCT07650032?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-08-01. Estimated completion is 2027-09-30.
What interventions are being tested in trial NCT07650032?
The interventions under investigation include: Ultra Low Temperature Ablation (ULTA) (DEVICE).
Who is sponsoring clinical trial NCT07650032?
This trial is sponsored by Adagio Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.